Tudor Investment Corp
MACK

Tudor Investment Corp’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Tudor Investment Corp’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,726
Closed -$46K – 1363
2017
Q2 		$46K Buy
4,726
+1,445
+44% +$29.5K ﹤0.01% 984
2017
Q1 		$80K Sell
3,281
-2,465
-43% -$61.7K ﹤0.01% 1320
2016
Q4 		$184K Buy
+5,746
New +$245K ﹤0.01% 1242
2016
Q3 		– Sell
-1,449
Closed -$61K – 1876
2016
Q2 		$61K Sell
1,449
-813
-36% -$44.3K ﹤0.01% 1544
2016
Q1 		$149K Buy
+2,262
New +$118K ﹤0.01% 1560
2015
Q1 		– Sell
-1,550
Closed -$138K – 1722
2014
Q4 		$138K Buy
+1,550
New +$113K ﹤0.01% 1341
2014
Q3 		– Sell
-1,731
Closed -$99K – 1568
2014
Q2 		$99K Buy
+1,731
New +$87.9K ﹤0.01% 1103

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tudor Investment Corp's MACK Position: Q3 2017 in Review

Tudor Investment Corp sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2017, closing a stake of 4,726 shares — an estimated $46K sold.

Tudor Investment Corp first reported a position in MACK in Q2 2014 and held it in 7 quarters. The position peaked at $184K in Q4 2016. 73 funds tracked by Wall St. Rank hold MACK as of Q3 2017.

  • Tudor Investment Corp reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Tudor Investment Corp sold 4,726 Merrimack Pharmaceuticals, Inc. shares in Q3 2017, an estimated $46K.
  • Tudor Investment Corp first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2014 and held it in 7 quarters.
  • Tudor Investment Corp's Merrimack Pharmaceuticals, Inc. position peaked at $184K in Q4 2016.
  • 73 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.